STEFANIE XENAKIS: Open Payments
NPI 1801316831 · APEX, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 79 payments from 20 companies in 2025. Trend: 2023 $2,462 · 2024 $2,622 · 2025 $1,451
Food & beverage: $1,451
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $299 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $245 |
| Corium, LLC | 9 | $198 |
| ABBVIE INC. | 14 | $172 |
| Collegium Pharmaceutical, Inc. | 4 | $74 |
| Janssen Pharmaceuticals, Inc | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Supernus Pharmaceuticals, Inc. | 3 | $42 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $37 |
Products named: REXULTI, CAPLYTA, Azstarys, VRAYLAR, Jornay PM, SPRAVATO, HETLIOZ, Qelbree.
Industry payments across NC — which companies pay providers there.
